Yonghe Wu

2.5k total citations · 1 hit paper
33 papers, 1.4k citations indexed

About

Yonghe Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yonghe Wu has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yonghe Wu's work include Epigenetics and DNA Methylation (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yonghe Wu is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yonghe Wu collaborates with scholars based in China, Germany and Argentina. Yonghe Wu's co-authors include Dietmar Spengler, Alexandre V. Patchev, Osborne F. X. Almeida, Chris Murgatroyd, D. Fischer, Vincenzo Micale, Carsten T. Wotjak, Guillaume Daniel, Ulrich Renner and Peter Lichter and has published in prestigious journals such as Nature Neuroscience, Oncogene and Endocrinology.

In The Last Decade

Yonghe Wu

31 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamic DNA methylation programs persistent adverse effects of early-life stress

2009 871 citations Chris Murgatroyd, Alexandre V. Patchev et al. Nature Neuroscience profile →

Peers

Yonghe Wu

MB

PPCH

BN

SP

GENET

Adam J. Funk United States

Alexandre V. Patchev Germany

Hanna E. Stevens United States

Kathryn Gudsnuk United States

Renaud Massart Canada

Stefanie L. Bronson United States

Volodymyr Yerko Canada

Dirk Moser Germany

Janine Arloth Germany

Ian C. Hellstrom Canada

Adam J. Funk United States

Yonghe Wu

623 ×1.0

MB

271 ×0.8

PPCH

288 ×0.9

BN

251 ×0.8

SP

236 ×1.1

GENET

Citations per year, relative to Yonghe Wu Yonghe Wu (= 1×) peers Adam J. Funk

Countries citing papers authored by Yonghe Wu

Since Specialization

Citations

This map shows the geographic impact of Yonghe Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghe Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghe Wu more than expected).

Fields of papers citing papers by Yonghe Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghe Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghe Wu. The network helps show where Yonghe Wu may publish in the future.

Co-authorship network of co-authors of Yonghe Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghe Wu. A scholar is included among the top collaborators of Yonghe Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghe Wu. Yonghe Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Fu, Minjie, Mengli Zhang, Licheng Zhang, et al.. (2025). Transketolase attenuates the chemotherapy sensitivity of glioma cells by modulating R-loop formation. Cell Reports. 44(1). 115142–115142. 3 indexed citations

2.

Huang, Ze‐Ning, Yonghe Wu, Yu‐Bin Ma, et al.. (2025). Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China. BMC Cancer. 25(1). 460–460. 2 indexed citations

3.

Man, K, Yonghe Wu, Zhen‐Jiang Gao, et al.. (2024). SOX10 mediates glioblastoma cell-state plasticity. EMBO Reports. 25(11). 5113–5140. 2 indexed citations

4.

Chen, Shumin, et al.. (2024). The USP35-CXCR3 Axis plays an oncogenic role in JeKo-1 mantle cell lymphoma cells. Integrative Biology. 16. 1 indexed citations

5.

Wu, Yonghe, Baohua Yu, Qunling Zhang, et al.. (2024). PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis. Blood Research. 59(1). 36–36. 2 indexed citations

6.

Wang, Changwen, Meng Sun, Chunxuan Shao, et al.. (2024). A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs. npj Precision Oncology. 8(1). 19–19. 14 indexed citations

7.

Chu, Youjun, et al.. (2024). A tumorigenicity evaluation platform for cell therapies based on brain organoids. Translational Neurodegeneration. 13(1). 53–53. 3 indexed citations

8.

Mok, Tony, Yonghe Wu, Milada Zemanová, et al.. (2024). MA06.07 Patterns of Progression with Lorlatinib and Insights into Subsequent Anticancer Therapy Efficacy in Advanced ALK+ NSCLC. Journal of Thoracic Oncology. 19(10). S75–S75. 3 indexed citations

9.

Zhang, Jinsen, Yuan Feng, Guanghao Li, et al.. (2023). Distinct aneuploid evolution of astrocytoma and glioblastoma during recurrence. npj Precision Oncology. 7(1). 97–97. 3 indexed citations

10.

Wu, Jiamin, et al.. (2022). Research on the Mechanism of Liuwei Dihuang Decoction for Osteoporosis Based on Systematic Biological Strategies. Evidence-based Complementary and Alternative Medicine. 2022. 1–22. 4 indexed citations

11.

Li, Hengyuan, et al.. (2022). EP08.01-071 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Non-Squamous NSCLC. Journal of Thoracic Oncology. 17(9). S374–S374. 1 indexed citations

12.

Zhang, Jinsen, Minjie Fu, Jinfeng Wu, et al.. (2022). The Anti-Glioma Effect of Juglone Derivatives through ROS Generation. Frontiers in Pharmacology. 13. 911760–911760. 10 indexed citations

13.

Wu, Yonghe, et al.. (2022). EP08.01-070 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC. Journal of Thoracic Oncology. 17(9). S373–S374. 1 indexed citations

14.

Wang, Qi, et al.. (2021). Integrative Ranking of Enhancer Networks Facilitates the Discovery of Epigenetic Markers in Cancer. Frontiers in Genetics. 12. 664654–664654. 1 indexed citations

15.

Lucia, K., Yonghe Wu, Anne Barlier, et al.. (2020). Hypoxia and the hypoxia inducible factor 1α activate protein kinase A by repressing RII beta subunit transcription. Oncogene. 39(16). 3367–3380. 22 indexed citations

16.

Poschet, Gernot, Yannic Nonnenmacher, Holger M. Becker, et al.. (2017). Branched‐chain ketoacids secreted by glioblastoma cells via MCT 1 modulate macrophage phenotype. EMBO Reports. 18(12). 2172–2185. 88 indexed citations

17.

Gerez, Juan, Juán José Bonfiglio, Mariana Fuertes, et al.. (2014). RSUME inhibits VHL and regulates its tumor suppressor function. Oncogene. 34(37). 4855–4866. 18 indexed citations

18.

Wu, Yonghe, Bing Shan, Christian P. Schaaf, et al.. (2013). Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas. Journal of Neuro-Oncology. 113(3). 385–396. 15 indexed citations

19.

Murgatroyd, Chris, et al.. (2010). Genes learn from stress: How infantile trauma programs us for depression. Epigenetics. 5(3). 194–199. 85 indexed citations

20.

Murgatroyd, Chris, Alexandre V. Patchev, Yonghe Wu, et al.. (2009). Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nature Neuroscience. 12(12). 1559–1566. 871 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact